HEIDELBERG PHARMA AG (HPHA.DE) Stock Analyst Ratings
Europe - Frankfurt Stock Exchange - FRA:HPHA - DE000A11QVV0 - Common Stock
3.04 EUR
-0.02 (-0.65%)
ChartMill assigns a Buy % Consensus number of 83% to HPHA.DE. The Buy consensus is the weighted average rating of the current analysts ratings.
- Analysts have set a mean price target forecast of 5.61. This target is 84.54% above the current price.
- HPHA.DE was analyzed by 8 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about HPHA.DE.
- In the previous month the buy percentage consensus was at a similar level.
- HPHA.DE was analyzed by 8 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
HEIDELBERG PHARMA AG / HPHA.DE FAQ
What do analysts expect the price target to be for HEIDELBERG PHARMA AG (HPHA.DE)?
8 analysts have analysed HPHA.DE and the average price target is 5.61 EUR. This implies a price increase of 84.54% is expected in the next year compared to the current price of 3.04.
What is the consensus rating for HEIDELBERG PHARMA AG (HPHA.DE) stock?
The consensus rating for HEIDELBERG PHARMA AG (HPHA.DE) is 82.5 / 100 . This indicates that analysts generally have a positive outlook on the stock.
Can you provide the analyst count for HEIDELBERG PHARMA AG stock?
The number of analysts covering HEIDELBERG PHARMA AG (HPHA.DE) is 8.